UnitedHealthcare
Zykadia (ceritinib)
Drugs for Cancer : Drugs for Cancer
  • Quantity Limit: limit maximum 1 EA PER 1 day(s)
  • Hemophilia A (Factor VIII):
    Duration: 3 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): Hematologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 3 month(s)
    Dosing Limit(s): <= 100
    Diagnosis Type(s): Mild
    Diagnosis Treatments: 1 of Bleeding episodes;Peri-procedural operative management
    Treatment Center Required: No

    Von Willebrand Disease:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Dosing Limit(s): N/A
    Treatment Center Required: No
    Dosing Limits Exist: No